Good news!
"Key takeaways
- UCLA has opened the Center for Advanced Biotherapies, a 14,000-square-foot FDA-compliant manufacturing facility that nearly doubles the institution’s capacity to produce cell and gene therapies for patients enrolled in clinical trials.
- The facility — built with support from the National Institutes of Health and the California Institute for Regenerative Medicine — is equipped to manufacture a broad range of personalized treatments, from cancer vaccines to stem cell gene therapies.
- The facility’s proximity to UCLA’s hospitals and clinics means researchers can move a therapy from the manufacturing suite to an early phase clinical trial patient’s bedside the same day.
For 30 years, the UCLA Human Gene and Cell Therapy Facility has been the quiet engine behind some of the university’s most ambitious clinical research, supporting more than 25 clinical trials and producing over 300 personalized therapy products for patients with cancer, HIV/AIDS, sickle cell disease and rare genetic disorders. But the science consistently exceeded what the space was designed for. ...
The center features 10 cleanrooms, including seven manufacturing suites designed to run multiple therapies simultaneously, two bioengineering rooms built for large-scale equipment, including bioreactors and 3D printers, and a dedicated suite for viral vector manufacturing. A centralized quality control laboratory supports comprehensive product testing and release. ..."
Three researchers in full white protective suits and gloves work inside a sterile cleanroom laboratory, viewed through a glass door.
No comments:
Post a Comment